Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 160,247 | 99,101 | 51,720 | 95,883 | 119,332 |
| Marketable Securities | 487,568 | 514,628 | 609,616 | 617,951 | 644,660 |
| Receivables | 73,321 | 73,345 | 56,557 | 46,906 | 75,277 |
| Inventories | 73,288 | 75,687 | 74,403 | 70,054 | 62,402 |
| TOTAL | $814,331 | $785,712 | $815,970 | $848,941 | $926,241 |
| Non-Current Assets | |||||
| PPE Net | 45,855 | 45,610 | 43,272 | 39,001 | 37,420 |
| Intangibles | 2,199 | 2,200 | 2,027 | 1,946 | 2,091 |
| Other Non-Current Assets | 84,121 | 84,927 | 84,659 | 96,368 | 96,238 |
| TOTAL | $132,175 | $132,737 | $129,958 | $137,315 | $135,749 |
| Total Assets | $946,506 | $918,449 | $945,928 | $986,256 | $1,061,990 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 40,073 | 40,020 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,948 | 2,702 | 4,330 | 9,061 | 7,089 |
| Accrued Expenses | 58,586 | 71,411 | 59,946 | 65,376 | 58,504 |
| Other current liabilities | 4,232 | 4,097 | 4,103 | 4,197 | 4,437 |
| TOTAL | $106,839 | $118,230 | $68,379 | $78,634 | $70,030 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 305,529 | 306,057 | 346,608 | 310,823 | 310,533 |
| TOTAL | $305,529 | $306,057 | $346,608 | $310,823 | $310,533 |
| Total Liabilities | $412,368 | $424,287 | $414,987 | $389,457 | $380,563 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 117,425 | 117,268 | 120,081 | 124,071 | 131,455 |
| Common Shares | 117 | 117 | 124 | 125 | 131 |
| Retained earnings | -953,726 | -980,653 | -999,374 | -903,275 | -910,325 |
| Other shareholders' equity | 800 | 652 | -2,644 | -4,722 | 514 |
| TOTAL | $534,138 | $494,162 | $530,941 | $596,799 | $681,427 |
| Total Liabilities And Equity | $946,506 | $918,449 | $945,928 | $986,256 | $1,061,990 |